Hangzhou Tigermed Consulting Dividends and Buybacks
Dividend criteria checks 0/6
Hangzhou Tigermed Consulting is a dividend paying company with a current yield of 0.93%.
Key information
0.9%
Dividend yield
-0.4%
Buyback Yield
| Total Shareholder Yield | 0.6% |
| Future Dividend Yield | 0.9% |
| Dividend Growth | 10.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.612 |
| Payout ratio | 51% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 3347 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 3347 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Hangzhou Tigermed Consulting Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (3347) | 0.9% |
| Market Bottom 25% (HK) | 3.3% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Life Sciences) | 1.0% |
| Analyst forecast (3347) (up to 3 years) | 0.9% |
Notable Dividend: 3347's dividend (0.93%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.28%).
High Dividend: 3347's dividend (0.93%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.05%).
Earnings Payout to Shareholders
Earnings Coverage: 3347 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: 3347 is not paying a notable dividend for the Hong Kong market.